Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 1/20 | 0.76 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.75 |
| ▸ | ACHE | P22303 | 1/20 | 0.68 |
| ▸ | CA12 | O43570 | 4/20 | 0.64 |
| ▸ | CA1 | P00915 | 4/20 | 0.64 |
| ▸ | CA9 | Q16790 | 4/20 | 0.64 |
| ▸ | CA2 | P00918 | 2/20 | 0.64 |
| ▸ | CA7 | P43166 | 2/20 | 0.57 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | TYR | P14679 | 1/20 | 0.53 |
| ▸ | MGAM | O43451 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20991565 | 1.00 | SNCA (0.76) | SNCAPTGS1ACHECA12CA1 | |
| SCHEMBL126741 | 1.00 | SNCA (0.76) | SNCAPTGS1ACHECA12CA1 | |
| SCHEMBL28807082 | 1.00 | SNCA (0.76) | SNCAPTGS1ACHECA12CA1 | |
| SCHEMBL1646800 | 1.00 | SNCA (0.76) | SNCAPTGS1ACHECA12CA1 | |
| SCHEMBL29412397 | 1.00 | SNCA (0.76) | SNCAPTGS1ACHECA12CA1 | |
| SCHEMBL9482158 | 1.00 | SNCA (0.76) | SNCAPTGS1ACHECA12CA1 | |
| SCHEMBL1646304 | 1.00 | SNCA (0.76) | SNCAPTGS1ACHECA12CA1 | |
| SCHEMBL9482170 | 1.00 | SNCA (0.76) | SNCAPTGS1ACHECA12CA1 | |
| Alcohol SCHEMBL6250759 | 0.98 | SNCA (0.72) | SNCAPTGS1ACHECA12CA1 | |
| SCHEMBL14691303 | 0.95 | SNCA (0.69) | SNCAPTGS1ACHECA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130863-A1 | SLOW-RELEASE FORMULATION | GLYCOSCIENCE, S.L. (ES) | 2026-05-14 | — | — | US | claimed |
| EP-4344398-B1 | SLOW-RELEASE FORMULATION | GLYCOSCIENCE S L (ES) | 2026-02-11 | — | — | EP | claimed |
| US-12533323-B2 | Slow-release formulation | GLYCOSCIENCE, S.L. (ES) | 2026-01-27 | — | — | US | claimed |
| US-12516357-B1 | Modified host cells for high efficiency production of vanillin | Amyris, Inc. (US) | 2026-01-06 | — | — | US | claimed |
| US-12480101-B2 | Modified host cells for high efficiency production of vanillin | Amyris, Inc. (US) | 2025-11-25 | — | — | US | claimed |
| WO-2025233177-A1 | LONG-DURATION FORMULATION | GLYCOSCIENCE, S.L. (ES) | 2025-11-13 | — | — | WO | claimed |
| EP-4646930-A1 | LONG-DURATION FORMULATION | Glycoscience, S.L. (ES) | 2025-11-12 | — | — | EP | claimed |
| CN-114174489-B | Modified host cells for efficient production of vanillin | 阿迈瑞斯公司 | 2024-11-08 | — | — | CN | claimed |
| CN-118434282-A | Sustained release preparation | 格莱克科学有限公司 | 2024-08-02 | — | — | CN | claimed |
| US-20240238216-A1 | SLOW-RELEASE FORMULATION | GLYCOSCIENCE, S.L. (ES) | 2024-07-18 | — | — | US | claimed |
| US-20140065261-A1 | Enzymatic Process | GIVAUDAN SA (CH) | 2014-03-06 | — | — | US | claimed |
| EP-2375918-B1 | ENZYMATIC PROCESS | GIVAUDAN SA (CH) | 2014-02-19 | — | — | EP | claimed |
| US-8580322-B2 | Enzymatic process | GIVAUDAN SA (CH) | 2013-11-12 | — | — | US | claimed |
| EP-2375918-A1 | ENZYMATIC PROCESS | Givaudan SA (CH) | 2011-10-19 | — | — | EP | claimed |
| US-20110244074-A1 | ENZYMATIC PROCESS | GIVAUDAN SA | 2011-10-06 | — | — | US | claimed |
| US-20110081448-A1 | PROCESS FOR TREATING VANILLA BEANS | FIRMENICH SA | 2011-04-07 | — | — | US | claimed |
| WO-2010066060-A1 | ENZYMATIC PROCESS | GIVAUDAN SA (CH) | 2010-06-17 | — | — | WO | claimed |
| US-6800175-B2 | PAPER HAND TOWELS; INTRODUCING A VANILLA COMPOUND (E.G., VANILLIN) INTO THE AQUEOUS SUSPENSION OF PAPERMAKING FIBERS | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-10-05 | — | — | US | claimed |
| WO-2004061230-A1 | PROCESS FOR MANUFACTURING A CELLULOSIC PAPER PRODUCT EXHIBITING REDUCED MALODOR | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-07-22 | — | — | WO | claimed |
| US-20040118537-A1 | Process for manufacturing a cellulosic paper product exhibiting reduced malodor | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-06-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12533323-B2 | Slow-release formulation | MAN2A1, GMDS, MAN2B2 | SNCA 4214/4885PTGS1 2772/4885ACHE 127/4885 |
| US-20240238216-A1 | SLOW-RELEASE FORMULATION | SORD, G6PD, GMDS | SNCA 3765/4885PTGS1 3088/4885ACHE 380/4885 |
| US-20260130863-A1 | SLOW-RELEASE FORMULATION | HEXD, GMDS, MAN2A1 | SNCA 4595/4885PTGS1 1658/4885ACHE 143/4885 |
| US-12480101-B2 | Modified host cells for high efficiency production of vanillin | UGGT1, ENGASE, GALE | SNCA 3586/4885PTGS1 2197/4885ACHE 4282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.